By Ian Walker
PureTech Health shares fell in early trading as private equity investor Nordic Capital withdrew its plan to buy the company after its approach was rejected.
Shares were down 15.20 pence, or 11%, at 123.0 pence in early morning European trading. They are currently down 18% over the year to date.
The biotherapeutics company said late Monday that it had been in talks with Nordic Capital about a possible cash offer for the company. It didn't give any indication of terms or pricing being discussed.
PureTech had a market capitalization of 331.9 million pounds ($422.3 million) based on its closing share price of 138.20 pence on Monday.
Separately, Nordic Capital confirmed that it had made a private proposal to PureTech Health that was rejected. It added that it no longer planned to table any firm offer for the company.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
April 08, 2025 03:23 ET (07:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。